93 Pages Medical Care
Available Formats
This report focuses on the global Hemophilia Gene Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemophilia Gene Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
uniQure
Freeline Therapeutics
Market segment by Type, the product can be split into
Hemophilia A
Hemophilia B
Market segment by Application, split into
Hemophilia A Gene Therapy
Hemophilia B Gene Therapy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hemophilia Gene Therapy status, future forecast, growth opportunity, key market and key players.
To present the Hemophilia Gene Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Hemophilia Gene Therapy are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
If you have any special requirements, please let us know and we will offer you the report as you want.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemophilia Gene Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hemophilia A
1.4.3 Hemophilia B
1.5 Market by Application
1.5.1 Global Hemophilia Gene Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hemophilia A Gene Therapy
1.5.3 Hemophilia B Gene Therapy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Hemophilia Gene Therapy Market Perspective (2015-2026)
2.2 Hemophilia Gene Therapy Growth Trends by Regions
2.2.1 Hemophilia Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemophilia Gene Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Hemophilia Gene Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemophilia Gene Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Hemophilia Gene Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hemophilia Gene Therapy Players by Market Size
3.1.1 Global Top Hemophilia Gene Therapy Players by Revenue (2015-2020)
3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemophilia Gene Therapy Market Concentration Ratio
3.2.1 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemophilia Gene Therapy Revenue in 2019
3.3 Hemophilia Gene Therapy Key Players Head office and Area Served
3.4 Key Players Hemophilia Gene Therapy Product Solution and Service
3.5 Date of Enter into Hemophilia Gene Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Hemophilia Gene Therapy Historic Market Size by Type (2015-2020)
4.2 Global Hemophilia Gene Therapy Forecasted Market Size by Type (2021-2026)
5 Hemophilia Gene Therapy Breakdown Data by Application (2015-2026)
5.1 Global Hemophilia Gene Therapy Market Size by Application (2015-2020)
5.2 Global Hemophilia Gene Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hemophilia Gene Therapy Market Size (2015-2020)
6.2 Hemophilia Gene Therapy Key Players in North America (2019-2020)
6.3 North America Hemophilia Gene Therapy Market Size by Type (2015-2020)
6.4 North America Hemophilia Gene Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hemophilia Gene Therapy Market Size (2015-2020)
7.2 Hemophilia Gene Therapy Key Players in Europe (2019-2020)
7.3 Europe Hemophilia Gene Therapy Market Size by Type (2015-2020)
7.4 Europe Hemophilia Gene Therapy Market Size by Application (2015-2020)
8 China
8.1 China Hemophilia Gene Therapy Market Size (2015-2020)
8.2 Hemophilia Gene Therapy Key Players in China (2019-2020)
8.3 China Hemophilia Gene Therapy Market Size by Type (2015-2020)
8.4 China Hemophilia Gene Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hemophilia Gene Therapy Market Size (2015-2020)
9.2 Hemophilia Gene Therapy Key Players in Japan (2019-2020)
9.3 Japan Hemophilia Gene Therapy Market Size by Type (2015-2020)
9.4 Japan Hemophilia Gene Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hemophilia Gene Therapy Market Size (2015-2020)
10.2 Hemophilia Gene Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemophilia Gene Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Hemophilia Gene Therapy Market Size by Application (2015-2020)
11 India
11.1 India Hemophilia Gene Therapy Market Size (2015-2020)
11.2 Hemophilia Gene Therapy Key Players in India (2019-2020)
11.3 India Hemophilia Gene Therapy Market Size by Type (2015-2020)
11.4 India Hemophilia Gene Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hemophilia Gene Therapy Market Size (2015-2020)
12.2 Hemophilia Gene Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemophilia Gene Therapy Market Size by Type (2015-2020)
12.4 Central & South America Hemophilia Gene Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Spark Therapeutics
13.1.1 Spark Therapeutics Company Details
13.1.2 Spark Therapeutics Business Overview and Its Total Revenue
13.1.3 Spark Therapeutics Hemophilia Gene Therapy Introduction
13.1.4 Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020))
13.1.5 Spark Therapeutics Recent Development
13.2 Ultragenyx
13.2.1 Ultragenyx Company Details
13.2.2 Ultragenyx Business Overview and Its Total Revenue
13.2.3 Ultragenyx Hemophilia Gene Therapy Introduction
13.2.4 Ultragenyx Revenue in Hemophilia Gene Therapy Business (2015-2020)
13.2.5 Ultragenyx Recent Development
13.3 Shire PLC
13.3.1 Shire PLC Company Details
13.3.2 Shire PLC Business Overview and Its Total Revenue
13.3.3 Shire PLC Hemophilia Gene Therapy Introduction
13.3.4 Shire PLC Revenue in Hemophilia Gene Therapy Business (2015-2020)
13.3.5 Shire PLC Recent Development
13.4 Sangamo Therapeutics
13.4.1 Sangamo Therapeutics Company Details
13.4.2 Sangamo Therapeutics Business Overview and Its Total Revenue
13.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Introduction
13.4.4 Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020)
13.4.5 Sangamo Therapeutics Recent Development
13.5 Bioverativ
13.5.1 Bioverativ Company Details
13.5.2 Bioverativ Business Overview and Its Total Revenue
13.5.3 Bioverativ Hemophilia Gene Therapy Introduction
13.5.4 Bioverativ Revenue in Hemophilia Gene Therapy Business (2015-2020)
13.5.5 Bioverativ Recent Development
13.6 BioMarin
13.6.1 BioMarin Company Details
13.6.2 BioMarin Business Overview and Its Total Revenue
13.6.3 BioMarin Hemophilia Gene Therapy Introduction
13.6.4 BioMarin Revenue in Hemophilia Gene Therapy Business (2015-2020)
13.6.5 BioMarin Recent Development
13.7 uniQure
13.7.1 uniQure Company Details
13.7.2 uniQure Business Overview and Its Total Revenue
13.7.3 uniQure Hemophilia Gene Therapy Introduction
13.7.4 uniQure Revenue in Hemophilia Gene Therapy Business (2015-2020)
13.7.5 uniQure Recent Development
13.8 Freeline Therapeutics
13.8.1 Freeline Therapeutics Company Details
13.8.2 Freeline Therapeutics Business Overview and Its Total Revenue
13.8.3 Freeline Therapeutics Hemophilia Gene Therapy Introduction
13.8.4 Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020)
13.8.5 Freeline Therapeutics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
If you have any special requirements, please let us know and we will offer you the report as you want.
List of Tables
Table 1. Hemophilia Gene Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Hemophilia Gene Therapy Revenue
Table 3. Ranking of Global Top Hemophilia Gene Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hemophilia A
Table 6. Key Players of Hemophilia B
Table 7. Global Hemophilia Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hemophilia Gene Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hemophilia Gene Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hemophilia Gene Therapy Market Share by Regions (2015-2020)
Table 11. Global Hemophilia Gene Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hemophilia Gene Therapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hemophilia Gene Therapy Market Growth Strategy
Table 17. Main Points Interviewed from Key Hemophilia Gene Therapy Players
Table 18. Global Hemophilia Gene Therapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hemophilia Gene Therapy Market Share by Players (2015-2020)
Table 20. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Gene Therapy as of 2019)
Table 21. Global Hemophilia Gene Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hemophilia Gene Therapy Product Solution and Service
Table 24. Date of Enter into Hemophilia Gene Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hemophilia Gene Therapy Market Size Share by Type (2015-2020)
Table 28. Global Hemophilia Gene Therapy Revenue Market Share by Type (2021-2026)
Table 29. Global Hemophilia Gene Therapy Market Size Share by Application (2015-2020)
Table 30. Global Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hemophilia Gene Therapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hemophilia Gene Therapy Market Share (2019-2020)
Table 34. North America Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hemophilia Gene Therapy Market Share by Type (2015-2020)
Table 36. North America Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hemophilia Gene Therapy Market Share by Application (2015-2020)
Table 38. Europe Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hemophilia Gene Therapy Market Share (2019-2020)
Table 40. Europe Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hemophilia Gene Therapy Market Share by Type (2015-2020)
Table 42. Europe Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hemophilia Gene Therapy Market Share by Application (2015-2020)
Table 44. China Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hemophilia Gene Therapy Market Share (2019-2020)
Table 46. China Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. China Hemophilia Gene Therapy Market Share by Type (2015-2020)
Table 48. China Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. China Hemophilia Gene Therapy Market Share by Application (2015-2020)
Table 50. Japan Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hemophilia Gene Therapy Market Share (2019-2020)
Table 52. Japan Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hemophilia Gene Therapy Market Share by Type (2015-2020)
Table 54. Japan Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hemophilia Gene Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hemophilia Gene Therapy Market Share (2019-2020)
Table 58. Southeast Asia Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hemophilia Gene Therapy Market Share by Type (2015-2020)
Table 60. Southeast Asia Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hemophilia Gene Therapy Market Share by Application (2015-2020)
Table 62. India Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hemophilia Gene Therapy Market Share (2019-2020)
Table 64. India Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. India Hemophilia Gene Therapy Market Share by Type (2015-2020)
Table 66. India Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. India Hemophilia Gene Therapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hemophilia Gene Therapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hemophilia Gene Therapy Market Share (2019-2020)
Table 70. Central & South America Hemophilia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hemophilia Gene Therapy Market Share by Type (2015-2020)
Table 72. Central & South America Hemophilia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hemophilia Gene Therapy Market Share by Application (2015-2020)
Table 74. Spark Therapeutics Company Details
Table 75. Spark Therapeutics Business Overview
Table 76. Spark Therapeutics Product
Table 77. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$)
Table 78. Spark Therapeutics Recent Development
Table 79. Ultragenyx Company Details
Table 80. Ultragenyx Business Overview
Table 81. Ultragenyx Product
Table 82. Ultragenyx Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$)
Table 83. Ultragenyx Recent Development
Table 84. Shire PLC Company Details
Table 85. Shire PLC Business Overview
Table 86. Shire PLC Product
Table 87. Shire PLC Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$)
Table 88. Shire PLC Recent Development
Table 89. Sangamo Therapeutics Company Details
Table 90. Sangamo Therapeutics Business Overview
Table 91. Sangamo Therapeutics Product
Table 92. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$)
Table 93. Sangamo Therapeutics Recent Development
Table 94. Bioverativ Company Details
Table 95. Bioverativ Business Overview
Table 96. Bioverativ Product
Table 97. Bioverativ Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$)
Table 98. Bioverativ Recent Development
Table 99. BioMarin Company Details
Table 100. BioMarin Business Overview
Table 101. BioMarin Product
Table 102. BioMarin Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$)
Table 103. BioMarin Recent Development
Table 104. uniQure Company Details
Table 105. uniQure Business Overview
Table 106. uniQure Product
Table 107. uniQure Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$)
Table 108. uniQure Recent Development
Table 109. Freeline Therapeutics Business Overview
Table 110. Freeline Therapeutics Product
Table 111. Freeline Therapeutics Company Details
Table 112. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2015-2020) (Million US$)
Table 113. Freeline Therapeutics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophilia Gene Therapy Market Share by Type: 2020 VS 2026
Figure 2. Hemophilia A Features
Figure 3. Hemophilia B Features
Figure 4. Global Hemophilia Gene Therapy Market Share by Application: 2020 VS 2026
Figure 5. Hemophilia A Gene Therapy Case Studies
Figure 6. Hemophilia B Gene Therapy Case Studies
Figure 7. Hemophilia Gene Therapy Report Years Considered
Figure 8. Global Hemophilia Gene Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Hemophilia Gene Therapy Market Share by Regions: 2020 VS 2026
Figure 10. Global Hemophilia Gene Therapy Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Hemophilia Gene Therapy Market Share by Players in 2019
Figure 13. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Gene Therapy as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2019
Figure 15. North America Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Hemophilia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Spark Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020)
Figure 24. Ultragenyx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020)
Figure 26. Shire PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020)
Figure 28. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020)
Figure 30. Bioverativ Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020)
Figure 32. BioMarin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020)
Figure 34. uniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020)
Figure 36. Freeline Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
If you have any special requirements, please let us know and we will offer you the report as you want.
If you have any special requirements, please let us know and we will offer you the report as you want.